Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Statistics & Valuation Metrics

Shuttle Pharmaceuticals Holdings, Inc. has a market cap or net worth of $2.01M. The enterprise value is -$1.39M.

Shuttle Pharmaceuticals Holdings, Inc. has 10,984,291 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shuttle Pharmaceuticals Holdings, Inc.’s return on equity (ROE) is -12.90 and return on invested capital (ROIC) is -368.06%.

The current PE Ratio of Shuttle Pharmaceuticals Holdings, Inc. is >-0.01. Shuttle Pharmaceuticals Holdings, Inc.’s PEG ratio is 0.03.

In the last 12 months, Shuttle Pharmaceuticals Holdings, Inc. had revenue of 0.00 and earned -9.14B in profits. Earnings per share was -3.19K.

In the last 12 months, operating cash flow was -8.62M and capital expenditures 0.00, giving a free cash flow of -8.62M billion.

Shuttle Pharmaceuticals Holdings, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Shuttle Pharmaceuticals Holdings, Inc. upcoming earnings date is Sep 4, 2024, TBA Not Confirmed.

Shuttle Pharmaceuticals Holdings, Inc. as a current ratio of 1.44, with Debt / Equity ratio of 33.61%

In the past 12 months, Shuttle Pharmaceuticals Holdings, Inc. has paid 0.00 in taxes.

Shuttle Pharmaceuticals Holdings, Inc. EV to EBITDA ratio is >-0.01, with an EV/FCF ratio of -0.23.

Shuttle Pharmaceuticals Holdings, Inc. has $4.51M in cash and marketable securities with $1.10M in debt, giving a net cash position of -$3.41M billion.

Gross margin is -16.74%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Shuttle Pharmaceuticals Holdings, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―